Albireo Pharma Inc (ALBO) Insider Trading
- $30,497,757.32
- $24,910,009.42
- Jan. 23, 2023
- Pamela Stephenson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 13, 2020 | CFO | 97 | $16.52 | Sell | $1,602.44 | |
March 25, 2020 | Insider | 1,785 | $17.60 | Sell | $31,416.00 | |
Feb. 3, 2020 | Major Shareholder | 255,809 | $21.00 | Buy | $5,371,989.00 | |
Jan. 22, 2020 | Insider | 443 | $24.29 | Sell | $10,760.47 | |
Jan. 10, 2020 | CFO | 105 | $27.20 | Sell | $2,856.00 | |
Nov. 13, 2018 | Insider | 1,026 | $25.02 | Buy | $25,670.52 | |
Aug. 14, 2018 | Insider | 788 | $31.85 | Buy | $25,097.80 | |
June 13, 2018 | COO | 25,000 | $32.26 | Sell | $806,500.00 | |
Jan. 30, 2018 | Major Shareholder | 100,000 | $34.44 | Sell | $3,444,000.00 | |
Jan. 25, 2018 | Major Shareholder | 275,000 | $33.00 | Buy | $9,075,000.00 | |
Dec. 1, 2017 | Major Shareholder | 500,000 | $21.40 | Sell | $10,700,000.00 | |
Dec. 20, 2013 | Director | 4,734 | $2.26 | Sell | $10,698.84 |
Insiders are both buying and selling Albireo Pharma Inc stock.
The insider traders at Albireo Pharma Inc are: Pamela Stephenson, Simon N.R. Harford, Jason Duncan, Ronald Harold Wilfred Cooper, Patrick Taylor Horn, Martha J Carter, Jan Mattsson, Perceptive Advisors Llc, Life Sciences Maste Perceptive, Brian Jg Pereira, Phase4 Partners Ltd, Plc Astrazeneca, and Harford Simon N.R.
The most active insider trader at Albireo Pharma Inc is Pamela Stephenson with 14 trades.
Plc Astrazeneca has sold the most Albireo Pharma Inc stock with a total value of $21,400,000.00.
Life Sciences Maste Perceptive has bought the most Albireo Pharma Inc stock with a total value of $41,075,000.00.
The most recent insider trade for Albireo Pharma Inc was on Jan. 23, 2023.
The single biggest insider buy for Albireo Pharma Inc was from Life Sciences Maste Perceptive with a total value of $16,000,000.00 on Sept. 14, 2020.
The single biggest insider sell for Albireo Pharma Inc was from Plc Astrazeneca with a total value of $10,700,000.00 on Dec. 1, 2017.